MaassenVanDenBrink A

ORCID: 0000-0001-7176-126X · 6 papers in corpus
2026
European journal of neurology ·doi:10.1111/ene.70597

BackgroundRecent post-marketing studies have indicated a possible association between anti-CGRP receptor monoclonal antibodies (anti-CGRP-mAbs) used for migraine prophylaxis and an increased risk of hypertension (HT).MethodsWe performed a r…

review 2023
Expert review of neurotherapeutics ·doi:10.1080/14737175.2023.2296610

INTRODUCTION: Migraine, a neurovascular headache disorder, is a leading cause of disability worldwide. Within the multifaceted pathophysiology of migraine, hormonal fluctuations play an evident triggering and exacerbating role, pointing tow…

2020
Frontiers in neurology ·doi:10.3389/fneur.2020.549038

Migraine is a common neurovascular disorder affecting ~15% of the general population. Ranking second in the list of years lived with disability (YLD), people living with migraine are greatly impacted by this especially burdensome primary he…

2019
Cephalalgia : an international journal of headache ·doi:10.1177/0333102417739584

BackgroundMigraine is two to three times more prevalent in women than in men, but the mechanisms involved in this gender disparity are still poorly understood. In this respect, calcitonin gene-related peptide (CGRP) plays a key role in migr…

2018
The journal of headache and pain ·doi:10.1186/s10194-018-0896-5

We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a consensus procedure among international experts was undertaken to develop statements to…

2017
The journal of headache and pain ·doi:10.1186/s10194-017-0815-1

Several data indicate that migraine, especially migraine with aura, is associated with an increased risk of ischemic stroke and other vascular events. Of concern is whether the risk of ischemic stroke in migraineurs is magnified by the use …